Predictive pre-treatment value of the Prognostic Nutritional Index on survival in gastric carcinoma
DOI:
https://doi.org/10.23938/ASSN.0271Keywords:
Gastric carcinoma. Pre-treatment predictive value. Prognostic nutritional index. Survival. Prognostic indicator.Abstract
Background. The Prognostic Nutritional Index (PNI) combines the values of circulating lymphocytes and serum albumin and, in the Asian literature; it has been related with the prognosis following R0 resection of gastric cancer. No results are available in Western countries. We study the possible independent prognostic value, at the moment of the tumour’s diagnosis, of PNI on survival.
Patients and methods. We review 234 consecutive gastric carcinomas, calculating global survival and tumour-specific survival. We considered pre-treatment PNI values of < 40 to be pathological. We carried out a univariate and multivariate analysis of cases of survival according to PNI, including the following adjustment variables: age > 70 years, ASA anaesthetic at the time of diagnosis, size of the neoplasia > 5cm, macroscopic type, undifferentiated degree and TNM clinical stage through echoendoscopy and/or CAT.
Results. The univariate analysis registered greater global and specific survival in cases with PNI ≥ 40 versus PNI < 40: [HR = 2.28; CI 95% = (1.60-3.26); p< 0.001] and [HR = 2.35; CI 95% = (1.63-3.39); p< 0.001], respectively. The multivariate analysis confirmed a better independent prognosis in cases with OI ≥ 40: global survival: [HR = 1.48; CI 95% = (1.02-2.16); p = 0.040], specific survival: [HR = 1.51; CI 95% = (1.03-2.23); p = 0.036].
Conclusions. At the moment of diagnosis of gastric cancer and including all registered cases, a PNI ≥ 40 is accompanied by a significantly greater global and tumour-specific survival. In our series, this better prognosis is independent of the patient’s age group, his/her ASA classification, the size and degree of differentiation of the neoplasia and its TNM clinical stage.
Downloads
References
1. SIEGEL R, NAISHADHAM D, JEMAL A. Cancer statistics. CA Cancer J Clin 2012; 62: 10-29.
https://doi.org/10.3322/caac.20138
2. ARDANAZ E, MORENO-IRIBAS C, PÉREZ DE RADA ME, EZPONDA C, FLORISTÁN Y, NAVARIDAS N et al. Incidencia y mortalidad por cáncer en Navarra. Evolución en los últimos 30 años. An Sist Sanit Navar 2007; 30: 245-270.
https://doi.org/10.4321/S1137-66272007000300009
3. KARIMI P, ISLAMI F, ANANDASABAPATHY S, FREEDMAN ND, KAMANGAR F. Gastric cancer: descriptive epidemiology, risk factors, screening and prevention. Cancer Epidemiol Biomarkers Prev 2014; 23: 700-713.
https://doi.org/10.1158/1055-9965.EPI-13-1057
4. Globocan 2012. Estimated cancer incidence, mortality and prevalence worldwide in 2012. Internacional Agency Research Cancer. OMS. (http://globocan.iarc.fr)
5. MIGITA K, TAKAYAMA T, SAEKI K, MATSUMOTO S, WAKATSUKI K, ENOMOTO K et al. The prognostic nutritional index predicts long-term outcomes of gastric cancer independent of tumor stage. Ann Surg Oncol 2013; 20: 2647-2654.
https://doi.org/10.1245/s10434-013-2926-5
6. LORENZEN S, BLANK S, OTT K. Prediction of response and prognosis including only pretherapeutic parameters in 410 neoadyuvant treated gastric cancer patients. Ann Surg Oncol 2012; 19: 2119-2127.
https://doi.org/10.1245/s10434-012-2254-1
7. VIÚDEZ A, MIRANDA C, ARIAS DE LA VEGA F, HERNÁNDEZ GARCÍA I, ARTAJONA A, DÍAZ DE LIAÑO A et al. Situación actual en el tratamiento del cáncer gástrico. Rev Esp Enf Dig 2012; 104: 134-141.
https://doi.org/10.4321/S1130-01082012000300006
8. CHANG L, STEFANIDIS D, RICHARDSON WS, EARLE DB, FANELLI RD. The role of staging laparoscopy for intra-abdominal cancers: an evidence-based review. Surg Endosc 2009; 23: 231-241.
https://doi.org/10.1007/s00464-008-0099-2
9. WANG Z, CHEN JQ. Imaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review. BMC Gastroenterology 2011; 11: 19.
https://doi.org/10.1186/1471-230X-11-19
10. PARK SR, KIM MJ, RYU KW, LEE JH, LEE JS, NAM BH et al. Prognostic value of preoperative clinical staging assessed by computed tomography in resectable gastric cancer patients. A view point in the era of preoperative treatment. Ann Surg 2010; 251: 428-435.
https://doi.org/10.1097/SLA.0b013e3181ca69a7
11. SUN K, CHEN S, XU J, LI G, HE Y. The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis. J Cancer Res Clin Oncol 2014; 140: 1537-1549.
https://doi.org/10.1007/s00432-014-1714-3
12. ISHIZUKA M, OYAMA Y, ABE A, TAGO K, TANAKA G, KUBOTA K. Prognostic nutritional index is associated with survival after total gastrectomy for patients with gastric cancer. Anticancer Res 2014; 34: 4223-4230.
13. PAN QX, SU ZJ, ZHANG JH, WANG CR, KE SY. A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer. Onco Targets Ther 2015; 8: 1375-1385.
https://doi.org/10.2147/OTT.S82437
14. BORDA F, BORDA A, ZOZAYA JM, URMAN J, JIMÉNEZ J, IBÁÑEZ B. Valor pronóstico del Indice de Onodera en la supervivencia del cáncer colorrectal. An Sist Sanit Navar 2014; 37: 213-221.
https://doi.org/10.4321/S1137-66272014000200004
15. ONODERA T, GOSEKI N, KOSAKI G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 1984; 85: 1001-1005.
16. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011; 14: 101-112.
https://doi.org/10.1007/s10120-011-0041-5
17. SHIN SH, BAE JM, JUNG H, CHOI MG, LEE JH, NOH JH et al. Clinical significance of the discrepancy between preoperative and postoperative diagnoses in gastric cancer patients. J. Surg Oncol 2010; 101: 384-388.
https://doi.org/10.1002/jso.21500
18. ROXBURGH CS, MCMILLAN DC. Role of system inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 2010; 6: 149-163.
https://doi.org/10.2217/fon.09.136
19. PROCTOR MJ, MORRISON DS, TALWAR D, BALMER SM, O'REILLY DS, FOULIS AK et al. An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. Br J Cancer 2011; 104: 726-734.
https://doi.org/10.1038/sj.bjc.6606087
20. YING HQ, DENG QW, HE BS, PAN YQ, WANG F, SUN HL. The prognostic value of the preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients. Med Oncol 2014; 31: 305.
https://doi.org/10.1007/s12032-014-0305-0
21. HE W, YIN C, GUO G, JIANG C, WANG F, QIU H et al. Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. Med Oncol 2013; 30: 439.
https://doi.org/10.1007/s12032-012-0439-x
22. NOZOE T, NINOMIYA M, MAEDA T, MATSUKUMA A, NAKASHIMA H, EZAKI T. Prognostic nutritional index: a tool to predict the biological aggressiveness of gastric carcinoma. Surg Today 2010; 40: 440-443.
https://doi.org/10.1007/s00595-009-4065-y
23. WATANABE M, IWATSUKI M, IWAGAMI S, ISHIMOTO T, BABA Y, BABA H. Prognostic nutritional index predicts outcomes of gastrectomy in the elderly. World J Surg 2012; 36: 1632-1639.
https://doi.org/10.1007/s00268-012-1526-z
24. PHILIP M, ROWLEY DA, SCHREIBER H. Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol 2001; 14: 433-439.
https://doi.org/10.1016/j.semcancer.2004.06.006
25. LI QQ, LU ZH, YANG L, LU M, ZHANG XT, LI J. Neutrophil count and the inflammation-based Glascow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy. Asian Pac J Cancer Prev 2014; 15: 945-950.
https://doi.org/10.7314/APJCP.2014.15.2.945
26. COUPLAND VH, LAGERGREN J, KONFORTION J, ALLUM W, MENDALL MA, HARDWICK RH et al. Ethnicity in relation to incidence of oesophageal and gastric cancer in England. Br J Cancer 2012; 107: 1908-1914.
https://doi.org/10.1038/bjc.2012.465
27. SAKURAI K, OHIRA M, TAMURA T, TOYOKAWA T, AMANO R, KUBO N et al. Predictive potential of preoperative nutritional status in long-term outcome projections for patients with gastric cancer. Ann Surg Oncol 2016; 23: 525-533.
https://doi.org/10.1245/s10434-015-4814-7
28. JIANG N, DENG JY, DING XW, KE B, LIU N, ZHANG RP et al. Prognostic nutritional index predicts postoperative complications and long-term outcomes of gastric cancer. World J Gastroenterol 2014; 20: 10537-10544.
https://doi.org/10.3748/wjg.v20.i30.10537
29. SUN YK, XU JB, CHEN SL, YUAN YJ, WU H, PENG JJ et al. Novel immnunological and nutritional-based prognostic index for gastric cancer. World J Gastroenterol 2015; 21; 5961-5971.
https://doi.org/10.3748/wjg.v21.i19.5961
30. SACHLOVA M, MAJEK O, TUCEK S. Prognostic value scores based on malnutrition or systemic inflammatory response in patients with metastatic or recurrent gastric cancer. Nutr Cancer 2014; 66: 1362-1370.
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Anales del Sistema Sanitario de Navarra
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
